Inspire Medical Systems Expects FY24 Revenue Of $788M-$798M (Prior $775M-$785M) Vs $787.9M Est
Portfolio Pulse from Benzinga Newsdesk
Inspire Medical Systems has updated its full-year 2024 revenue guidance to a range of $788 million to $798 million, representing a 26% to 28% growth over 2023. This is an increase from the prior guidance of $775 million to $785 million.
July 29, 2024 | 10:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inspire Medical Systems has raised its full-year 2024 revenue guidance to $788 million to $798 million, up from the previous range of $775 million to $785 million. This new guidance represents a 26% to 28% growth over 2023.
The increase in revenue guidance suggests stronger-than-expected performance and growth prospects for Inspire Medical Systems. This positive outlook is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100